Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
(αS)-α-methylbenzeneethanamine
Desamfetamina
Dexamfetamine
Dexamfetaminum
(S)-α-methylbenzeneethanamine
(+)-amphetamine
Dextroamphetamine
(+)-(S)-amphetamine
(S)-(+)-β-phenylisopropylamine
(+)-α-methylphenethylamine
(S)-amphetamine
Dexanfetamina
Dextroamphetamine adipate
Dexamfetamina
(S)-(+)-amphetamine
(S)-1-phenyl-2-aminopropane
Dextroamphetamine saccharate
d-amphetamine
(+)-α-methylphenylethylamine
(S)-1-phenyl-2-propylamine
Dextroamphetamine sulfate
Dexamphetamine
Brand Names
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Mixed Salts of a Single Entity Amphetamine Product XR
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
